Cullinan Therapeutics (CGEM) Institutional Ownership $7.56 +0.07 (+0.87%) As of 12:14 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Cullinan Therapeutics (NASDAQ:CGEM)CurrentInstitutional OwnershipPercentage86.31%Number ofInstitutional Buyers(last 12 months)96TotalInstitutional Inflows(last 12 months)$155.42MNumber ofInstitutional Sellers(last 12 months)41TotalInstitutional Outflows(last 12 months)$34.55M Get CGEM Insider Trade Alerts Want to know when executives and insiders are buying or selling Cullinan Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data CGEM Institutional Buying and Selling by Quarter Cullinan Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Tower Research Capital LLC TRC 8,182$62K0.0%+44.6%0.014% 8/15/2025 Rafferty Asset Management LLC39,226$295K0.0%-28.6%0.066% 8/15/2025 Man Group plc22,341$168K0.0%N/A0.038% 8/15/2025 Massar Capital Management LP13,418$101K0.1%N/A0.023% 8/15/2025 Engineers Gate Manager LP18,124$136K0.0%N/A0.031% 8/15/2025 Brevan Howard Capital Management LP19,227$145K0.0%-52.6%0.033% 8/15/2025 Bank of America Corp DE661,285$4.98M0.0%+26.1%1.119% 8/15/2025 Ameriprise Financial Inc.45,292$341K0.0%N/A0.077% 8/14/2025 Jane Street Group LLC48,883$368K0.0%+42.1%0.083% 8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.29,854$225K0.0%-10.4%0.051% Get the Latest News and Ratings for CGEM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cullinan Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/14/2025 Nebula Research & Development LLC31,853$240K0.0%-26.6%0.054% 8/14/2025 Qube Research & Technologies Ltd67,119$505K0.0%N/A0.114% 8/14/2025 Voss Capital LP251,717$1.90M0.1%+43.8%0.426% 8/13/2025 Tema Etfs LLC42,692$321K0.1%+9.0%0.072% 8/13/2025 Marshall Wace LLP626,581$4.72M0.0%+10.3%1.061% 8/13/2025 Walleye Capital LLC35,199$265K0.0%+60.0%0.060% 8/13/2025 Invesco Ltd.60,555$456K0.0%+23.0%0.103% 8/13/2025 Virtus Investment Advisers LLC10,506$79K0.0%-21.9%0.018% 8/13/2025 Russell Investments Group Ltd.40,986$309K0.0%+39.6%0.069% 8/12/2025 Foresite Capital Management VI LLC594,025$4.47M2.5%-6.4%1.006% 8/12/2025 XTX Topco Ltd43,095$325K0.0%-3.1%0.073% 8/12/2025 American Century Companies Inc.125,189$943K0.0%+11.1%0.212% 8/12/2025 Rhumbline Advisers74,105$558K0.0%+3.9%0.125% 8/12/2025 Legal & General Group Plc18,858$142K0.0%-55.9%0.032% 8/12/2025 Franklin Resources Inc.2,228,160$16.78M0.0%+0.4%3.772% 8/12/2025 JPMorgan Chase & Co.97,069$731K0.0%+122.9%0.164% 8/12/2025 Swiss National Bank50,300$379K0.0%-19.8%0.085% 8/11/2025 Patient Square Capital LP868,897$6.54M2.4%-1.1%1.472% 8/8/2025 Intech Investment Management LLC37,372$281K0.0%-25.1%0.063% 8/8/2025 Creative Planning41,723$314K0.0%+222.2%0.071% 8/8/2025 Geode Capital Management LLC1,279,496$9.64M0.0%+3.0%2.168% 8/7/2025 Connor Clark & Lunn Investment Management Ltd.70,044$527K0.0%-9.8%0.119% 8/5/2025 Corton Capital Inc.21,712$163K0.2%+28.9%0.037% 8/1/2025 Y Intercept Hong Kong Ltd11,129$84K0.0%N/A0.019% 7/31/2025 AlphaQuest LLC10,464$79K0.0%-58.3%0.018% 6/27/2025 Goldman Sachs Group Inc.648,957$4.91M0.0%-5.3%1.100% 5/29/2025 Rhumbline Advisers71,338$540K0.0%+4.6%0.121% 5/23/2025 Siren L.L.C.1,193,410$9.03M0.5%-1.5%2.022% 5/21/2025 Acadian Asset Management LLC81,721$618K0.0%N/A0.138% 5/19/2025 Jane Street Group LLC34,396$260K0.0%-145.9%0.058% What's the Best Way to Lower RMD Taxes? (Ad)Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain retirement accounts. Without the right strategy, these withdrawals can significantly increase your tax bill and shrink your nest egg. SmartAsset outlines six strategies that could help reduce your RMDs and potentially lower your tax burden. Their free tool can match you with vetted fiduciary financial advisors in your area—professionals legally bound to act in your best interest.Click here to see the six strategies and get your free advisor matches today.5/16/2025 Woodline Partners LP81,741$619K0.0%-51.1%0.139% 5/16/2025 Goldman Sachs Group Inc.648,957$4.91M0.0%-5.3%1.100% 5/16/2025 Dynamic Technology Lab Private Ltd21,581$163K0.0%N/A0.037% 5/16/2025 Millennium Management LLC783,177$5.93M0.0%-6.1%1.327% 5/15/2025 Braidwell LP980,773$7.42M0.3%-16.6%1.662% 5/15/2025 Siren L.L.C.1,193,410$9.03M0.5%-1.5%2.022% 5/15/2025 Tema Etfs LLC39,164$296K0.1%+37.7%0.066% 5/15/2025 Trexquant Investment LP68,467$518K0.0%N/A0.116% 5/14/2025 Rafferty Asset Management LLC54,942$416K0.0%-38.7%0.093% 5/14/2025 Walleye Capital LLC22,000$167K0.0%-85.9%0.037% 5/14/2025 AlphaQuest LLC25,090$190K0.0%N/A0.043% 5/14/2025 Martingale Asset Management L P22,132$168K0.0%-42.6%0.038% 5/14/2025 EntryPoint Capital LLC24,190$183K0.1%+65.0%0.041% 5/14/2025 Voss Capital LP175,000$1.33M0.1%+43.0%0.297% 5/14/2025 Wellington Management Group LLP161,057$1.22M0.0%+21.1%0.273% 5/13/2025 Brooklyn Investment Group4,503$34K0.0%N/A0.008% 5/13/2025 Algert Global LLC221,430$1.68M0.0%+411.5%0.375% 5/13/2025 American Century Companies Inc.112,670$853K0.0%+11.9%0.191% 5/13/2025 Russell Investments Group Ltd.29,363$222K0.0%N/A0.050% 5/12/2025 Nuveen LLC188,030$1.42M0.0%N/A0.319% 5/12/2025 Invesco Ltd.49,243$373K0.0%-17.3%0.083% 5/12/2025 Connor Clark & Lunn Investment Management Ltd.77,621$588K0.0%+282.9%0.132% 5/9/2025 Deutsche Bank AG575,531$4.36M0.0%-0.8%0.975% 5/9/2025 Charles Schwab Investment Management Inc.424,262$3.21M0.0%-1.6%0.719% 5/9/2025 Vanguard Group Inc.3,039,731$23.01M0.0%+3.5%5.151% 5/7/2025 Corton Capital Inc.16,842$127K0.4%+41.0%0.029% 4/22/2025 Palumbo Wealth Management LLC16,268$123K0.0%N/A0.028% 4/17/2025 Exchange Traded Concepts LLC14,107$107K0.0%+42.6%0.024% 4/15/2025 Assenagon Asset Management S.A.10,062$76K0.0%-92.4%0.017% 4/8/2025 Rhumbline Advisers71,338$540K0.0%+4.6%0.122% 4/7/2025 GAMMA Investing LLC6,995$53K0.0%+1,214.8%0.012% 3/24/2025 Wellington Management Group LLP132,976$1.62M0.0%+25.4%0.227% 3/18/2025 California State Teachers Retirement System31,251$381K0.0%-14.3%0.053% 2/17/2025 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC91,792$1.12M0.0%+29.4%0.158% 2/17/2025 Woodline Partners LP167,315$2.04M0.0%N/A0.287% 2/17/2025 Squarepoint Ops LLC19,101$233K0.0%-37.9%0.033% 2/17/2025 Two Sigma Advisers LP21,900$267K0.0%+22.3%0.038% 2/17/2025 Two Sigma Investments LP42,205$514K0.0%+83.9%0.072% 2/17/2025 Tema Etfs LLC28,433$346K0.1%N/A0.049% 2/17/2025 Sphera Funds Management LTD.205,000$2.50M0.5%+10.3%0.352% 2/17/2025 Rafferty Asset Management LLC89,658$1.09M0.0%-21.8%0.154% 2/17/2025 ProShare Advisors LLC17,326$211K0.0%+31.2%0.030% 2/17/2025 Patient Square Capital LP878,897$10.71M4.0%+6.6%1.509% 2/17/2025Nuveen Asset Management LLC227,033$2.77M0.0%-2.8%0.390% 2/17/2025 OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC56,095$683K0.1%+22.0%0.096% 2/17/2025 Orbimed Advisors LLC1,942,555$23.66M0.5%+81.5%3.336% 2/17/2025 Millennium Management LLC833,962$10.16M0.0%+5.8%1.432% 2/17/2025 D. E. Shaw & Co. Inc.48,932$596K0.0%-17.4%0.084% 2/17/2025 Deutsche Bank AG580,136$7.07M0.0%+3.4%0.996% 2/17/2025 Deerfield Management Company L.P. Series C3,379,399$41.16M0.8%+3.0%5.804% Forget Tesla — This Tiny AI Stock Is Musk’s Real Play (Ad)While Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it could transform warfare, robotics, and the global economy. But you don’t need to buy Tesla or wait for xAI to IPO to benefit. One overlooked public company is supplying the critical tech behind Musk’s AI push — and it trades for a fraction of Nvidia’s price. Hedge funds are already loading up, but most investors haven’t noticed yet.See the full details on this “backdoor” Musk bet here2/17/2025 Corton Capital Inc.11,944$145K0.1%N/A0.021% 2/17/2025 Cubist Systematic Strategies LLC130,647$1.59M0.0%N/A0.224% 2/17/2025 Brevan Howard Capital Management LP14,735$179K0.0%N/A0.025% 2/17/2025 Bank of America Corp DE155,270$1.89M0.0%-62.1%0.267% 2/17/2025 BNP Paribas Financial Markets115,000$1.40M0.0%N/A0.197% 2/17/2025 Ameriprise Financial Inc.504,264$6.14M0.0%+20.8%0.866% 2/17/2025 Algert Global LLC43,292$527K0.0%+8.5%0.074% 2/14/2025 Boxer Capital Management LLC907,895$11.06M0.9%N/A1.559% 2/14/2025 Foresite Capital Management VI LLC634,558$7.73M3.4%N/A1.090% 2/14/2025 Northern Trust Corp500,908$6.10M0.0%+6.4%0.860% (Data available from 1/1/2016 forward) CGEM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CGEM shares? During the previous two years, 133 institutional investors and hedge funds held shares of Cullinan Therapeutics. The most heavily invested institutionals were Deerfield Management Company L.P. Series C ($41.16M), State Street Corp ($39.13M), Blue Owl Capital Holdings LP ($28.88M), RTW Investments LP ($28.56M), Holocene Advisors LP ($25.67M), Alliancebernstein L.P. ($24.50M), and Orbimed Advisors LLC ($23.66M).Learn more on Cullinan Therapeutics' institutional investors. What percentage of Cullinan Therapeutics' stock is owned by institutional investors? 86.31% of Cullinan Therapeutics' stock is owned by institutional investors. Learn more on CGEM's institutional investor holdings. Which institutional investors have been buying Cullinan Therapeutics' stock? Of the 117 institutional investors that purchased Cullinan Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Deerfield Management Company L.P. Series C ($2.24M), Lynx1 Capital Management LP ($1.22M), Marshall Wace LLP ($1.20M), Braidwell LP ($1M), Boxer Capital Management LLC ($907.90K), Patient Square Capital LP ($878.90K), and Orbimed Advisors LLC ($872.50K). How much institutional buying is happening at Cullinan Therapeutics? Institutional investors have bought a total of 11,864,827 shares in the last 24 months. This purchase volume represents approximately $155.42M in transactions. Which of Cullinan Therapeutics' major shareholders have been selling company stock? Of the 41 institutional investors that sold Cullinan Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Marshall Wace LLP ($402.07K), Adage Capital Partners GP L.L.C. ($325.44K), Walleye Capital LLC ($306.42K), CenterBook Partners LP ($254.68K), Bank of America Corp DE ($254.52K), Franklin Resources Inc. ($252.87K), and Braidwell LP ($195.40K). How much institutional selling is happening at Cullinan Therapeutics? Institutional investors have sold a total of 3,031,960 shares in the last 24 months. This volume of shares sold represents approximately $34.55M in transactions. Related Companies ARQT Major Shareholders VCEL Major Shareholders DYN Major Shareholders APGE Major Shareholders TWST Major Shareholders BEAM Major Shareholders CDTX Major Shareholders IMCR Major Shareholders BHVN Major Shareholders WVE Major Shareholders This page (NASDAQ:CGEM) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cullinan Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cullinan Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
